Muscles Susceptibility to Ischemia-Reperfusion Injuries Depends on Fiber Type Specific Antioxidant Level by Anne-Laure Charles et al.
ORIGINAL RESEARCH
published: 06 February 2017
doi: 10.3389/fphys.2017.00052
Frontiers in Physiology | www.frontiersin.org 1 February 2017 | Volume 8 | Article 52
Edited by:
Li Zuo,
Ohio State University, USA
Reviewed by:
Martina Krüger,
University of Düsseldorf, Germany
Han-Zhong Feng,
Wayne State University School of
Medicine, USA
Zewen Liu,
Ohio State University, USA
*Correspondence:
Bernard Geny
bernard.geny@chru-strasbourg.fr
†
These authors have contributed
equally to this work.
Specialty section:
This article was submitted to
Striated Muscle Physiology,
a section of the journal
Frontiers in Physiology
Received: 06 October 2016
Accepted: 19 January 2017
Published: 06 February 2017
Citation:
Charles A-L, Guilbert A-S, Guillot M,
Talha S, Lejay A, Meyer A, Kindo M,
Wolff V, Bouitbir J, Zoll J and Geny B
(2017) Muscles Susceptibility to
Ischemia-Reperfusion Injuries
Depends on Fiber Type Specific
Antioxidant Level. Front. Physiol. 8:52.
doi: 10.3389/fphys.2017.00052
Muscles Susceptibility to
Ischemia-Reperfusion Injuries
Depends on Fiber Type Specific
Antioxidant Level
Anne-Laure Charles 1, 2 †, Anne-Sophie Guilbert 1, 3 †, Max Guillot 1, 4, Samy Talha 1, 2,
Anne Lejay 1, 2, Alain Meyer 1, 2, Michel Kindo 1, 5, Valérie Wolff 1, 6, Jamal Bouitbir 7,
Joffrey Zoll 1, 2 and Bernard Geny 1, 2*
1 Equipe d’accueil 3072, Faculté de Médecine, Fédération de Médecine Translationnelle, Université de Strasbourg,
Strasbourg, France, 2 Service de Physiologie et d’Explorations Fonctionnelles, Pôle de Pathologie Thoracique, Nouvel Hôpital
Civil, CHRU de Strasbourg, Strasbourg, France, 3 Service de Réanimation Médico-Chirurgicale Pédiatrique Spécialisée,
Hôpital de Hautepierre, CHRU de Strasbourg, Strasbourg, France, 4 Service de Réanimation Médicale, Hôpital de
Hautepierre, CHRU de Strasbourg, Strasbourg, France, 5 Service de Chirurgie Cardio-Vasculaire, Pôle d’activité
Médico-chirurgicale Cardiovasculaire, Nouvel Hôpital Civil, CHRU de Strasbourg, Strasbourg, France, 6Unité
neurovasculaire, Hôpital de Hautepierre, CHRU de Strasbourg, Strasbourg, France, 7Division of Clinical Pharmacology and
Toxicology, University Hospital Basel, Basel, Switzerland
Muscle injury resulting from ischemia-reperfusion largely aggravates patient prognosis
but whether and how muscle phenotype modulates ischemia-reperfusion-induced
mitochondrial dysfunction remains to be investigated. We challenged the hypothesis
that glycolytic muscles are more prone to ischemia-reperfusion-induced injury than
oxidative skeletal muscles. We therefore determined simultaneously the effect of 3 h of
ischemia induced by aortic clamping followed by 2 h of reperfusion (IR, n = 11) on both
gastrocnemius and soleusmuscles, as compared to control animals (C, n= 11). Further,
we investigated whether tempol, an antioxidant mimicking superoxide dismutase,
might compensate a reduced defense system, likely characterizing glycolytic muscles
(IR-Tempol, n = 7). In the glycolytic gastrocnemius muscle, as compared to control,
ischemia-reperfusion significantly decreasedmitochondrial respiration (−30.28± 6.16%,
p= 0.003), increased reactive oxygen species production (+79.15± 28.72%, p= 0.04),
and decreased reduced glutathione (−28.19 ± 6.80%, p = 0.011). Less deleterious
effects were observed in the oxidative soleusmuscle (−6.44± 6.30%,+4.32± 16.84%,
and −8.07 ± 10.84%, respectively), characterized by enhanced antioxidant defenses
(0.63 ± 0.05 in gastrocnemius vs. 1.24 1± 0.08 µmol L− g−1 in soleus). Further,
when previously treated with tempol, glycolytic muscle was largely protected against the
deleterious effects of ischemia-reperfusion. Thus, oxidative skeletal muscles are more
protected than glycolytic ones against ischemia-reperfusion, thanks to their antioxidant
pool. Such pivotal data support that susceptibility to ischemia-reperfusion-induced injury
differs between organs, depending on their metabolic phenotypes. This suggests a need
to adapt therapeutic strategies to the specific antioxidant power of the target organ to
be protected.
Keywords: antioxidant, ischemia-reperfusion, metabolic phenotype, mitochondria, muscle, sarcopenia, oxidative
stress, peripheral arterial disease (PAD)
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INTRODUCTION
Lower limb ischemia is a frequent clinical problem resulting
from trauma, hemorrhage, vascular occlusion, and/or
thromboembolic events (Blaisdell, 2002; Ali et al., 2007;
Beekley et al., 2008). Surgical or medical reperfusion is needed
to avoid definitive necrosis, and previous studies showed that
muscle irreversible damages appear likely after 4 h of ischemia
(Belkin et al., 1988; Carvalho et al., 1997; Blaisdell, 2002; Martou
et al., 2006; Paradis et al., 2016). After 3 h of ischemia, injury
has shown to be reversible following 28 days of reperfusion. In
this case however, reversibility was likely afforded by muscle
regeneration (Vignaud et al., 2010; Itoh et al., 2013).
Albeit necessary, reintroduction of oxygenated blood into the
ischemic areas induces unfortunately ischemia-reperfusion (IR)
injury. This is significant, aggravating both local and general
prognosis of the patient (Harris et al., 1986; Blaisdell, 2002;
Martou et al., 2006) and supporting continuous work in order
to reduce these deleterious effects.
Recently major advances have been observed in our
knowledge of lower limb IR pathophysiology. Notably,
interactions between muscle mitochondria and reactive
oxygen species (ROS) have been emphasized (Lejay et al., 2014).
Oxidative stress, which precedes mitochondrial dysfunction,
arises during ischemia and is enhanced after reperfusion (Guillot
et al., 2014). This suggests that modulating ROS production
may reduce IR-induced injury. Accordingly, we and others
demonstrated that muscle mitochondrial function is protected
when ROS production is reduced and/or when the ROS
produced can be efficiently handled by the antioxidant system.
Such therapeutic approaches were based on both ischemic and
pharmacologic conditioning (Ali et al., 2007; Makris et al., 2007;
Charles et al., 2011; Tran et al., 2011; Talha et al., 2013).
Interestingly, however, interactions between mitochondria
and ROS are more subtle. Significant increases in ROS
production are generally considered deleterious because
it induces lipid peroxidation, protein carbonylation, and
mitochondrial dysfunction that is associated with reduced ATP
production (Anderson and Neufer, 2006; Magder, 2006). On
the other hand, a small ROS increase is a signaling pathway
stimulating mitochondrial biogenesis and enhancing antioxidant
defenses (Ristow, 2014; Yun and Finkel, 2014). Recently, we
reported that skeletal muscles are more prone to statin-induced
injury than cardiac muscles (Bouitbir et al., 2011). Metabolic
phenotypes greatly differ between cardiac and skeletal muscles.
Indeed, heart is highly oxidative, in association with enhanced
mitochondrial respiration and antioxidant system (Masuda et al.,
2003; Kowaltowski et al., 2009; Bouitbir et al., 2011).
Similar differences exist among skeletal muscles, which are
classified mainly depending on their contractile and/or metabolic
phenotype. Mammalian skeletal muscles are characterized by
their abilities to adapt to new conditions. Indeed, changes can
be detected by multiple sensors, from membrane receptors
for hormones and cytokines, to metabolic sensors that detect
variations in the high-energy phosphate concentration, oxygen
as well as oxygen free radicals. These sensors trigger cascades of
signaling pathways which may ultimately lead to changes in fiber
type, especially at the level of metabolic properties (for review see
Pourova et al., 2010; Schiaffino and Reggiani, 2011; Blaauw et al.,
2013; Zuo et al., 2015).
Particularly, certain fibers possess a large amount of
mitochondria, and rely mainly on oxidative phosphorylation.
These fibers can be defined as “oxidative:” they require more
oxygen and depend hence on the vascularisation to synthesize
ATP. On the other hand, other fibers possess few mitochondria,
and mainly rely on glycolysis to produce ATP. These fibers
can be identified as “glycolytic” (Jackman and Willis, 1996;
Meyer et al., 2014). Moreover, the analysis of the expression
myosin heavy chains enables to differentiate four subtypes of
slow (Type I) and fast twitch fibers: IIA, IIX, and IIB (Talbot
and Maves, 2016). Type I fiber, such as the soleus, is considered
as a slow oxidative fiber with high baseline respiratory rates and
important antioxidant pools. Type IIA fibers use both oxidative
and glycolytic metabolisms to produce ATP, and have a relatively
high mitochondrial content (however lower than type I fibers).
These fibers are relatively resistant to fatigue (Schiaffino, 2010).
Type IIB fibers possess a low amount of mitochondria and rely
mainly on glycolysis. These fibers has less antioxidant enzymes
compared with type I fibers (Powers andHamilton, 1999; Ploquin
et al., 2012) and are easily fatigable, but develop tremendous
amounts of strength. Type IIX fibers possess an intermediate
phenotype between type IIA and type IIB fibers. Based on these
characteristics, and on the fact that superficial gastrocnemius
present with 97% of type IIb fibers and that soleus present with
30.6% of type I fibers (Bloemberg and Quadrilatero, 2012), we
decided to study both superficial gastrocnemius and soleus in this
study.
Interestingly, although Turoczi et al. described a type I
muscle altered viability (Turóczi et al., 2014), other studies rather
supported glycolytic muscles alterations after IR. Particularly,
considering contractile force, Demirel et al. observed differences
between glycolytic and oxidative muscles submitted to IR. After
4 h ischemia and 2 h reperfusion, the force-frequency curve
was more altered in extensor digitorum longus (EDL) than in
soleus. Further, resistance to fatigue was lower in EDL than in
soleus (Demirel et al., 2013). Impaired fatigue resistance and
contraction were also observed after IR in gastrocnemius (Zhang
et al., 2017) and accordingly, proteins implicated in muscle
contraction are known to be targets for ROS (Beckendorf and
Linke, 2015), which are largely implicated in IR pathophysiology
(increased lipid peroxidation and oxidized proteins; Avci et al.,
2012).
Considering that oxidative skeletal muscles can also suffer
from intense IR (Ali et al., 2010; Balogh et al., 2014; Turóczi et al.,
2014; He and Zuo, 2015), we aimed to challenge the hypothesis
their susceptibility to IR injuries might depend on their metabolic
phenotypes. Particularly, oxidative skeletal muscles (as compared
to glycolytic ones) should be protected from IR injuries, thanks to
their antioxidant defenses.
MATERIALS AND METHODS
Ethical Approval
Procedures were conducted in accordance with US National
Institutes of Health guidelines. The study was approved by
the institutional animal care committee of the University
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of Strasbourg (Comité Régional d’Ethique en Matière
d’Expérimentation Animale de Strasbourg, CREMEAS, CEE35)
(AL/02/09/04/08).
Animals
We worked on adult male Wistar rats (Depré, Saint-Doulchard,
France) aged 8 weeks. The temperature environment is
regulated at 22 ± 2◦C, and the room is submitted to a
12-h light-dark cycle. Animals had free access to food and
water.
Preoperative Management
The anesthesia was induced in a hermetic cage with 4%
isoflurane (Aerrane, CSP, Cournon, France) and oxygen.
During the operation, the animals ventilated spontaneously,
with an oxygen-delivering mask, and adapted isoflurane
concentrations. The body temperature was controlled and
maintained (Homeothermic blanket control unit, MINERVE,
Harvard Apparatus R©, Esternay, France).
Surgical Procedures and Experimental
Design
Twenty nine rats were divided in three groups (Figure 1): the
control group (C, n = 11) underwent 5 h of general anesthesia.
A midline laparotomy was performed and the abdominal aorta
was exposed like in the IR groups.
The ischemia–reperfusion (IR) group (n= 11) underwent 3 h
of ischemia induced by infra-renal aortic occlusion, and collateral
vessel coagulation (GEIGER R©, thermal cautery unit, Geiger
Medical Technologies, Council Bluffs, Iowa, USA) followed by 2
h of reperfusion. As previously reported, ischemia was clinically
characterized by cyanosis and lack of arterial pulse distal to the
clamp and reperfusion was associated with recoloring and pulse
return in the hind limb (Thaveau et al., 2007;Mansour et al., 2011;
Pottecher et al., 2013).
FIGURE 1 | Experimental design. The control (C) animals (n = 11)
underwent 5 h of general anesthesia and a sham operation. The
ischemia-reperfusion (IR) animals (n = 11) underwent 3 h of ischemia induced
by infrarenal aortic occlusion (dark bar), followed by 2 h of reperfusion (open
bar). The TEMPOL-IR animals (n = 7) underwent the same IR protocol but 10
min before reperfusion, TEMPOL was injected (250mg Kg−1) intraperitoneally
(ip). A second ip injection was administered after 1 h reperfusion (125mg
Kg−1).
Duration of ischemia was based on our and previous data
demonstrating that 3 h ischemia is needed to result in significant
skeletal muscle injury, which is still more severe after 6 h
ischemia (Belkin et al., 1988; Thaveau et al., 2007). Chronological
sequences about the cellular and molecular events occurring
during skeletal muscle IR has been recently reported (Paradis
et al., 2016). Interestingly, as compared to the heart which is still
beating, such a long duration might be explained by the non-
contracting, resting skeletal muscle generally examined. Like in
the heart however (Ma et al., 2016), a no reflow occurrence might
increase with long ischemia time and we therefore choose a 3 h
ischemia period for our experimental protocol.
At the end of reperfusion, lactate, which is considered as a
good marker of anaerobic state, was determined on total blood
obtained from the tail before and after ischemia (lactate Pro
device, LT710, Arkray R©, KGK, Kyoto, Japan). Its decrease after
opening the artery supports a successful reperfusion (Noll et al.,
2012).
At the end of experiment, oxidative soleus and glycolytic
superficial gastrocnemius muscles were excised (Bloemberg and
Quadrilatero, 2012). For each muscle, one part was used
immediately for oxidative capacities and ROS determinations.
The second part was frozen in isopentane cooled by liquid
nitrogen or directly in liquid nitrogen and thereafter stored for
a later use.
Finally, to identify the role of oxidative stress in IR-related
injury, and particularly to determine the potential protective
effect of an anti-oxidant in gastrocnemius, a third group was given
the superoxide dismutase mimetic. Rats from the Tempol-IR
group (n = 7) had two intraperitoneal injections of 4-hydroxy-
2,2,6,6-tetramethylpiperidine-1-oxyl (Tempol, Sigma-Aldrich R©,
St. Louis, MO, USA); 250mg kg−1 at 10min before the beginning
of reperfusion and 125mg kg−1 after 1 h of reperfusion (Halter
et al., 2010).
Study of Muscle Mitochondrial Respiration
All used products were purchased from Sigma-Aldrich R© (St.
Louis, MO, USA).
We studied the mitochondrial respiration of skinned fibers
rather than isolated mitochondria to preserve the environment
and the integrity of mitochondria (Saks et al., 1998; Rasmussen
and Rasmussen, 2000). The two muscles studied were superficial
gastrocnemius and soleusmuscles.
Oxygen consumption was measured by using a Clark-
type electrode in an oxygraphic cell (Strathkelvin Instruments,
Glasgow, Scotland) as previously described (Kuznetsov et al.,
2008; Charles et al., 2011; Kindo et al., 2012, 2016). Maximal
oxidative respiration (Vmax) was measured after adding ADP
(2mmol L−1) as phosphate acceptor and glutamate (5 mmol
L−1)—malate (2mmol L−1) as mitochondrial substrates. Vmax
reflects the electron flow through complexes I, III, IV, and ATP
synthase.
Then, complex I was blocked with amobarbital (0.02mmol
L−1), and complex II was subsequently stimulated (Vsucc)
with succinate (25µmol L−1). The electron flow went through
complexes II, III, IV, and ATP synthase.
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Finally, N,N,N′,N′-tetra-methyl-p-phenylenediamine
dihydrochloride (TMPD, 0.5 mmol L−1) and ascorbate
(0.5 mmol L−1) were added as artificial electron donors
to cytochrome c, to study complex IV activity. After the
experiment, fibers were harvested and dried for 15 min at 150◦C,
and respiration rates were expressed as µmol O2 min
−1 g−1 dry
weight.
Electron Paramagnetic Resonance
Although one method might have been sufficient, we decided to
perform two complementary methods for ROS measurement in
order to comfort the data. DHE staining is very useful and allows
demonstrate the ROS level in tissue and EPR is viewed as an
excellent technique, measuring the ROS production by the tissue
(Dikalov et al., 2007; Kuznetsov et al., 2011; Lejay et al., 2015).
Electron Paramagnetic Resonance (EPR) allows determining
superoxide (O−2 ) formation.
O.−2 concentration was determined with a specific spin probe
1-hydroxy-3-methoxycarbonyl-2, 2, 5, 5-tetramethylpyrrolidine
hydrochloride (CMH, Noxygen R©, Elsach, Germany), oxidized by
impaired electron (Dikalov et al., 2007; Lejay et al., 2015; Kindo
et al., 2016).
All used substrates for the Krebs Hepes buffer were purchased
from Sigma-Aldrich R© (St. Louis, MO, USA).
Ten 2-mm pieces of muscles were cut and washed twice with
the Krebs Hepes Buffer (NaCl 99 mmol L−1; KCl 4.69 mmol
L−1; CaCl2 2.5 mmol L
−1; MgSO4 1.2 mmol L
−1; NaHCO3 25
mmol L−1; KH2PO4 1.03 mmol L
−1; D(+)Glucose 5.6 mmol
L−1; Na-hepes 20 mmol L−1; pH 7.4) containing 25 µmol L−1
deferoxamine and 5 µmol L−1 diethyldithiocarbamate (DETC)
to minimize CMH auto-oxidation. Then, they were incubated
in a plate at 37◦C with the spin probe CMH (200 µmol
L−1) for 30 min under controlled pressure (20 mmHg) and
gas mix (N2: 97.8%, O2: 2.8%) to mimic tissular environment
(Noxygen R©, Elsach, Germany). The incubation of tissues is
stopped by placing the plate on ice. Forty-one microliters of the
supernatant are injected in a disposable capillary tube, and placed
inside the cavity of the e-scan spectrometer (Bruker Win-EPR R©,
Elsach, Germany) for data acquisition at 15◦C (The used EPR
settings: Centre Field 3461.144 g, microwave power 21.85 mW,
modulation amplitude 2.40 G, sweep time 5.24 s (10 scans), sweep
width 60 G, number of lag curve points 1).
The amplitude of the signal is measured, and the
concentration of CM-radical is determined by calibration
with standard concentrations of the radicals CM. After the EPR
measurement, pieces of muscles are dried for 15 min at 150◦C,
and O.−2 production was expressed in µmol min
−1 mg−1 dry
weight.
Dihydroethidium Staining
Dihydroethidium staining (DHE, Sigma-Aldrich R©) allows
detecting the presence of ROS in skeletal muscles.
Frozen muscles were cut on serial sections (10 µm-thicks)
with a cryostat microtome and thaw mounted on glass slides
and incubated with DHE (2.5 µmol L−1). DHE produced red
fluorescence when oxidized to ethidium bromide (EtBr) by O.−2
(Mulsch et al., 2001; Talha et al., 2013; Guillot et al., 2014). As
compared to other markers, the interest of DHE is its relatively
good specificity to O.−2 .
After staining, sections were examined under an
epifluorescence microscope (Eclipse E800, Nikon, New York,
USA) with a 20X epifluorescence objective. The emission signal
was recorded with a Zeiss 573–637 nm filter. We analyzed
micrographs with Adobe Photoshop 6.0 (USA). The results were
reported in percentage of control group.
Measurement of Reduced Glutathione
The glutathione peroxidase is an important intracellular
antioxidant, because it is the primary enzyme responsible for
H2O2 detoxification in mitochondria (Antunes et al., 2002;
Zoccarato et al., 2004).
All used products were purchased from Sigma-Aldrich R© (St.
Louis, MO, USA).
Reduced glutathione (GSH) was measured in the different
muscles by monitoring the reduction of 5,5′-dithio-bis-(2-
nitrobenzoic acid) (DTNB) to 5-thio-2-nitrobenzoate (TNB) in
presence of GSH at 412 nm (Akerboom and Sies, 1981; Bouitbir
et al., 2011). Briefly, to determine GSH content, tissue samples
were mixed with cold 5% 5-sulfosalicylic acid, after 10 min of
incubation on ice, the mixture was centrifuged at 4000 rpm
for 10 min at 4◦C to remove proteins. The samples were then
diluted in cold MOPS buffer, at room temperature. The diluted
sample was added to glutathione reductase (24 units mL−1)
and MOPS (0.1mol L−1) containing 1 mmol L−1 EDTA, 0.3
mmol L−1 NADPH, and 0.22 mmol L−1 DTNB. The absorbance
was continuously monitored for 1 min, as an index of DTNB
reduction by GSH contained in the sample. Reduced glutathione
was expressed in µmol L−1 g−1.
Statistical Analysis
Values are expressed as mean ± SEM. n indicates the
number of animals. Statistical analyses were performed with
Student’s t-test for unpaired data. When the variances were
significantly different, we used the Student’s unpaired t-test with
Welch’s correction. For the lactate rates comparison statistical
significance was measured by ANOVA followed by the post-test
Newman Keuls (GraphPad Prism 5, Graph Pad Software, Inc.,
San Diego, CA, USA). Values of p < 0.05 were considered to be
statistically significant.
RESULTS
Ischemia Significantly Increased Blood
Lactates, Which Returned to Baseline
Values after Reperfusion (Figure 2)
Plasma lactate kinetic demonstrated the efficiency of IR. After 3
h ischemia, lactate increased significantly (10.9 ± 2.0 vs. 2.2 ±
0.2 mmol L−1,+395.4%; p < 0.001). Then, at reperfusion, lactate
decreased significantly (3.1 ± 0.5 vs. 10.9 ± 2.0 mmol L−1, p <
0.001) and there was no significant difference in lactate values
between before ischemia and after reperfusion (2.2 ± 0.2 vs. 3.1
± 0.5 mmol L−1, NS, respectively).
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FIGURE 2 | Lactate concentrations increased with ischemia and
returned to baseline level after reperfusion. Ischemia-reperfusion (IR)
group (gray bars), control group (white bars). Lactates levels were measured
before and after 3 h of ischemia, and after 2 h of reperfusion. Results were
expressed as mean ± SEM. ***p < 0.001 compared to after ischemia.
IR Impaired Mitochondrial Respiration,
Increased ROS Production, and Reduced
Antioxidant Defenses in Glycolytic
Gastrocnemius Muscles (Figure 3)
Mitochondrial Respiratory Chain Complex Activities
(Figure 3A)
In gastrocnemius, maximal respiration rate (Vmax), reflecting the
activity of complexes I, III, IV, and V, was significantly altered
after IR as compared to the control group (4.51± 0.44 vs. 6.61±
0.42 µmol O2 min
−1 g−1 dry weight, respectively, p < 0.05).
Similarly, Vsucc, reflecting the activity of complexes II, III, IV,
and V, was decreased after IR (3.82 ± 0.36 vs. 6.23 ± 0.61 µmol
O2 min
−1g−1 dry weight, respectively, p < 0.01).
Finally, VTMPD/Asc, reflecting the complex IV activity, was
decreased after IR (14.05± 1.92 vs. 20.61± 1.49 µmol O2 min
−1
g−1 dry weight compared to the control group, respectively, p <
0.05).
Thus, IR impaired all complexes of the mitochondrial
respiratory chain of the gastrocnemiusmuscle.
ROS Production (Figures 3B,C)
The graph B represents the O.−2 production measured by EPR,
demonstrating that O−2 production was significantly increased
compared to control group (0.09 ± 0.01 vs. 0.06 ± 0.01 µmol
mg−1 min−1, respectively, p= 0.037) in the gastrocnemius.
This result was confirmed in the graph C representing DHE
staining. Indeed, ROS content was increased after IR as compared
to the control group (36,860 ± 8127 vs. 16,720 ± 3674 UA,
respectively, p= 0.04).
Antioxidant Defenses (Figure 3D)
The reduced glutathione produced in gastrocnemiuswas critically
decreased after IR as compared to the control group (0.63± 0.05
vs. 0.45± 0.04 µmol L−1 g−1, p= 0.024, respectively).
Effects of IR on the Oxidative Soleus
Muscle (Figure 4)
Mitochondrial Respiratory Chain Complex Activities
(Figure 4A)
Less-IR induced damage is observed in oxidative muscle. In
soleus, the maximal respiration rate (Vmax), although showing
a slight tendency to decrease, was not significantly altered
after IR as compared to the control group (8.94 ± 0.60 vs.
9.56 ± 0.58 µmol O2 min
−1 g−1 dry weight, respectively,
p= 0.469).
Similarly, Vsucc, was not significantly modified after IR (8.99
± 0.43 vs. 10.05 ± 0.52 µmol O2 min
−1 g−1 dry weight,
respectively, p= 0.135).
VTMPD/Asc, showed the same profile and was not significantly
altered after IR, as compared to the control group (22.70 ± 1.32
vs. 25.88± 1.92 µmol O2 min
−1g−1 dry weight, respectively, p=
0.187).
ROS Production (Figures 4B,C)
Concerning the oxidative soleus, the graph B shows that O.−2
production was not modified as compared to the control group
(0.24± 0.01 vs. 0.22± 0.01 µmol mg−1 min−1, respectively, p=
0.36).
Further, the graph C confirmed that ROS content remained
unchanged after IR as compared to the control group
(109,300 ± 17,650 vs. 104,800 ± 10,640 UA, p = 0.83,
respectively).
Antioxidant Defenses (Figure 4D)
In the soleus, IR did not altered the reduced glutathione content
(1.14± 0.13 vs. 1.24± 0.08µmol L−1 g−1, p= 0.54, as compared
to the control group).
Taken together, these data demonstrate that unlike
the glycolytic muscle gastrocnemius, the oxidative
soleus is well-protected from IR-induced deleterious
effects.
Thus, the alteration of Vmax was markedly greater in
gastrocnemius than in soleus (−30.28 ± 6.17 vs. −6.44 ± 6.30%,
respectively, p = 0.014). Similarly, the alteration of Vsucc and
of VTMPD/Asc were largely enhanced in gastrocnemius compared
to soleus (−38.28 ± 5.31 vs. −10.54 ± 4.30%, respectively, p =
0.0006) and (−32.71 ± 8.48 vs. −12.29 ± 5.08%, p = 0.052),
respectively (Figure 5A).
Such lack of oxidative skeletal muscle alteration was associated
with an absence of oxidative stress.
Accordingly, ROS production increased more in
gastrocnemius than in soleus (+39.80 ± 16.32 vs. +8.36 ±
6.99% in gastrocnemius and soleus, respectively, p = 0.088,
Figure 5B).
Similar data were obtained when using DHE staining
(+79.15 ± 28.72 vs. +4.32 ± 16.84% of alteration
in gastrocnemius and soleus, respectively, p = 0.034,
Figure 5C).
Finally, the antioxidant defenses were reduced by IR only
in the gastrocnemius as compared to the soleus (−28.20
± 6.80 vs. −8.07 ± 10.84%, respectively, p = 0.148,
Figure 5D).
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FIGURE 3 | Ischemia-reperfusion impaired glycolytic gastrocnemiusmuscle, and an increase of antioxidant protected this muscle against an IR injury.
(A) Mitochondrial respiration in the gastrocnemius. (B,C) ROS production in the gastrocnemius: superoxide anion production measured by EPR with a specific probe
CMH (B) and intensity of fluorescence labeled with oxidative dye DHE (C). (D) Reduced glutathione in the gastrocnemius. The black bars represent the C group
(control group) and the gray bars represent the IR group (3 h of ischemia and 2 h of reperfusion). Vmax: complexes I, III, IV, V activities; Vsucc: complexes II, III, IV, V
activities; VTMPD/asc: complex IV activity. Results were expressed as mean ± SEM. *p < 0.05, **p < 0.01 compared to the control group.
$$p < 0.01, $$$p < 0.001
compared to the IR group. C, Control group; IR, Ischemia-reperfusion group. IR+T: TEMPOL-IR group.
Metabolic Phenotypes Implications in
Muscle Susceptibility to IR
The metabolic phenotype differs between gastrocnemius and
soleus muscles and might therefore explain their specific
sensitivity to IR.
Indeed, as compared to oxidative ones, glycolytic muscles
are characterized by lower mitochondrial respiratory chain
complex activities. This holds true for all complexes. Thus,
Vmax, Vsucc, and VTMPD/Asc are smaller in gastrocnemius
as compared to soleus (6.6 ± 0.4 vs. 9.6 ± 0.6; 6.2
Frontiers in Physiology | www.frontiersin.org 6 February 2017 | Volume 8 | Article 52
Charles et al. Ischemia-Reperfusion and Muscle Phenotype
FIGURE 4 | Ischemia-reperfusion effects on the oxidative soleus muscle. (A) Mitochondrial respiration in the soleus. (B,C) ROS production in the soleus:
superoxide anion production measured by EPR with a specific probe CMH (B) and intensity of fluorescence labeled with oxidative dye DHE (C). (D) Reduced
glutathione in the soleus. The black bars represent the C group (control group) and the gray bars represent the IR group (3 h of ischemia and 2 h of reperfusion). Vmax:
complexes I, III, IV, V activities; Vsucc: complexes II, III, IV, V activities; VTMPD/asc: complex IV activity. Results were expressed as mean ± SEM. C, Control group, IR,
Ischemia-reperfusion group.
± 0.6 vs. 10.0 ± 0.5; and 20.6 ± 1.5 vs. 25.9 ± 1.9
µmol O2 min
−1 g−1 dry weight, respectively, p < 0.001)
(Figures 3A, 4A).
Further, O.−2 production determined by EPR was
significantly lower in gastrocnemius than in soleus (0.059
± 0.007, 0.221 ± 0.012 µmol mg−1 min−1, respectively,
p < 0.001, Figures 3B, 4B). This is confirmed by DHE
staining demonstrating that ROS level was a six-fold lower in
gastrocnemius as compared to soleus (16,720 ± 3674 vs. 104,800
± 10,640 UA, p < 0.001, respectively, Figures 3C, 4C).
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FIGURE 5 | Ischemia reperfusion altered specifically glycolytic
compared to oxidative skeletal muscles. (A) IR-induced mitochondrial
respiration in the gastrocnemius (Gc) compared to the soleus (Sol) expressed
in %. (B,C) ROS production in the gastrocnemius (Gc) compared to the soleus
(Sol) expressed in %. Superoxide anion production measured by EPR with a
specific probe CMH (B) and intensity of fluorescence labeled with oxidative
dye DHE (C). (D) The use of IR-induced reduced glutathione was compared in
gastrocnemius (Gc) and soleus (Sol), and expressed in %. Results were
expressed as mean ± SEM. $p < 0.05, $$$p < 0.001 compared to
gastrocnemius.
Finally, gastrocnemius muscle antioxidant defenses, as
inferred from GSH are two-fold lower in gastrocnemius
compared to soleus (0.63 ± 0.05 vs. 1.24 ± 0.08 µmol L−1 g−1,
p < 0.0001, respectively, Figures 3D, 4D).
In view of these data we tested the hypothesis that the
reduced antioxidant defenses of gastrocnemius muscle might be
overcome by administration of tempol, an efficient antioxidant,
and therefore confer protection against IR to this glycolytic
muscle.
With tempol, mitochondrial oxidative capacities were no
longer impaired by IR in gastrocnemius (Figure 3A).
Thus, in the Tempol-IR group, Vmax was not impaired by IR
(9.25± 1.25, vs. 3.82± 0.36 µmol O2 min
−1g−1 dry weight, p <
0.001 and 6.23 ± 0.61 µmol O2 min
−1g−1 dry weight, p < 0.05,
for IR and control group, respectively).
Similarly, Vsucc was not impaired by IR (7.58 ± 0.90 vs. 3.82
± 0.36 µmol O2 min
−1g−1 dry weight, p < 0.01, and 6.23± 0.61
µmol O2 min
−1 g−1 dry weight, p=NS for IR and control group,
respectively). VTMPD/asc (16.24 ± 1.92) was not significantly
different from IR and control values (14.05 ± 1.92 and 20.61 ±
1.49 µmol O2 min
−1 g−1 dry weight, for IR and control group,
respectively).
DISCUSSION
The main result of this study is that skeletal muscle metabolic
phenotype importantly modulates deleterious effects of lower
limb IR. Thus, as compared to the glycolytic gastrocnemius,
the oxidative soleus appeared protected and demonstrated no
significant mitochondrial dysfunction. In soleus, higher anti-
oxidant capacity likely participates in such protection since
oxidative stress is a key factor inducing muscle impairment
during IR. Accordingly, when treated with an antioxidant,
gastrocnemius muscle acted as soleus, showing no more
significant alteration although submitted to the same IR
protocol.
Vascular ischemia is very common and corresponds to a
public health issue both because of its increasing occurrence
and its very bad prognosis (Yassin et al., 2002). Thus, major
amputation is still needed in 25–40% of cases, and the risk of
death is as high as 25% after the first clinical sign of peripheral
arteriopathy (Norgren et al., 2007; Taylor et al., 2009; Ryan et al.,
2015). Interestingly, muscle alteration significantly impacts both
local and general prognosis. Thus, rhabdomyolysis is well-known
to participate in remote organ alteration including kidneys, the
heart and lungs (Fowkes et al., 2006; Ali et al., 2007; McMahon
et al., 2013).
Although some therapeutic strategies have been shown
effective, results are not always consistent, raising the issue
of a specific organ dependency to IR (Mansour et al., 2014).
Concerning skeletal muscles, metabolic phenotype is a good
candidate since degrees of fiber injury vary among contractile
muscle phenotypes (Chan et al., 2004). Woitaske et al. observed
an increased mitochondrial swelling and disrupted sarcoplasmic
reticulum in the glycolytic EDL as compared to soleus muscle
(Woitaske and McCarter, 1998). Accordingly, IR- induced
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contractile dysfunction was recently shown to be reduced in
soleus as compared to EDL (Demirel et al., 2013).
Based on different muscle phenotypes, several mechanisms
might explain such potential increased sensitivity of glycolytic
muscle to IR injury. Particularly, mitochondrial content and
redox balance deserve discussion.
Mitochondrial density is about two-fold greater in oxidative
than in glycolytic muscles (Jackman and Willis, 1996; Picard
et al., 2008), likely participating in the enhanced mitochondrial
respiration observed in soleus as compared to gastrocnemius
muscles (Anderson and Neufer, 2006; Meyer et al., 2014).
Recently, induction of mitochondrial biogenesis has been shown
to protect against apoptosis in L6 myoblats (Dam et al., 2013),
and we observed that decrease in PGC1 beta, which likely
participate in mitochondrial biogenesis, resulted in a reduced
adaptation of muscles to cope with high energy demands
(Gali Ramamoorthy et al., 2015). Such relationship between
the number of mitochondria and muscle responses to stress
likely apply in the setting of IR. Accordingly, Flück et al.
demonstrated that IR-induced skeletal muscle rhabdomyolysis is
a fiber type-specific phenomenon, modulated by mitochondria
reserves (Fluck et al., 2015).
However, besides mitochondrial respiration per-se, redox
status appears to be a key factor in muscle functioning (for
review see Zuo and Pannell, 2015). Even during physiological
contraction (eccentric and/or concentric), muscle mitochondria
generate large amounts of ROS, that might allow either muscular
adaptation or muscular damage. Thus, depending likely on ROS
levels resulting from the pro-/antioxidant balance, consequences
might be good (mitochondrial biogenesis, antioxidant pathway
stimulation, enhanced glucose uptake), bad (mitochondrial
dysfunctions, reduced ATP synthesis) or even ugly (mPTP
opening and apoptosis) (Lejay et al., 2014; Zuo et al., 2015).
In this view, exercise is interesting to consider. Indeed,
exercise-related beneficial effects are largely reduced when
exercise-induced ROS signaling is decreased by enzymatic
inhibitors or antioxidant supplementation (Meier et al., 2013;
Strobel et al., 2014; Merry and Ristow, 2016). Further, the
effects of exercise likely depend on muscle metabolic phenotype.
For instance, exercise has a stronger influence on red muscle
phenotype, as compared to white muscle in salmonids (Morash
et al., 2014). Similarly, uphill-, as compared to down-hill training
enhanced mitochondrial function specifically in both soleus and
vastus intermedius skeletal muscle (Schlagowski et al., 2016).
Increased antioxidant defenses also characterize oxidative
muscles. This likely explains why statins optimize cardiac
mitochondria, but impairs skeletal muscle function by inducing
different levels of ROS (Bouitbir et al., 2011, 2015). Concerning
skeletal muscles, in agreement with previous reports (Anderson
and Neufer, 2006; Picard et al., 2012), we observed greater
FIGURE 6 | Schema illustrating skeletal muscle susceptibility to ischemia-reperfusion, depending on metabolic phenotype. Oxidative skeletal muscles
are characterized by increased mitochondrial content and enhanced antioxidant system allowing better protection against ischemia-reperfusion supported by
maintained mitochondrial respiration and low reactive oxygen species (ROS) production. Antioxidant adjunction protects glycolytic muscle, further demonstrating the
key role of oxidative stress handling and therefore muscle metabolic phenotype. SODs, Superoxide dismutases; GPX, glutathione peroxidase.
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glutathione peroxidase activity in the soleus than in the superficial
gastrocnemius This support that the oxidative skeletal muscle
may possess a greater capacity to scavenge ROS (Picard
et al., 2012). Since enhanced ROS production occur early and
participate significantly in IR deleterious effects (Tran et al., 2011;
Guillot et al., 2014; Lejay et al., 2014), the fact that oxidative
muscles naturally equip with higher antioxidant contents than
glycolytic muscles likely protect them in the setting of IR. Further,
an adaptation related to oxidative resistance might have been
triggered during IR. Such a possibility, likely working in the
setting of preconditioning, can perhaps not be totally developed
in the relatively short time frame of our study but, one might
suggest that the antioxidant pool located in the blood might also
have been mobilized.
To further test that enhanced antioxidant defenses allow
oxidative skeletal muscles being protected against IR, we
determined whether the glycolytic muscle gastrocnemius might
be protected against IR when its antioxidant defense is
improved. Accordingly, tempol therapy significantly attenuated
the deleterious effects of IR. Such data are in agreement with a
previous work (Tran et al., 2011) and further suggest a key role
of the antioxidant defenses and likely explain -at least partly- the
specific muscle susceptibility to IR (Figure 6).
As perspectives, further studies should be able to demonstrate
that ROS staining be mainly colocalized within type II
fibers during IR. It might be useful to determine the
molecular mechanisms involved in muscle protection, signaling
ranging from mitochondrial biogenesis to atrophy-hypertrophy
pathways. Besides ROS-activated signaling pathways such as
MAPK, PI3K/Akt signaling, PKC, and inflammation signaling
(Görlach et al., 2015), a special insight should be directed
toward the SAFE and RISK pathways which modified interplay
might account for increased susceptibility of diabetic muscles to
ischemia (Lejay et al., 2016).
CONCLUSION
This study supports that glycolytic muscles are more prone
to IR than oxidative ones. Such muscle susceptibility appears
linked to muscle metabolic phenotypes, involving mainly muscle
mitochondrial oxidative capacity and antioxidant defenses.
This might explain difficulties to convert experimental data
well-focused on specific muscle fibers toward clinical setting,
since human muscles show more phenotypic heterogeneity.
More widely, these data suggest that therapeutic approaches
should be adapted to target organ redox capacities (potentially
modified by comorbidities), and that mechanisms increasing
either mitochondrial function and/or antioxidant defense should
allow better protection.
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